Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)226.35
  • Today's Change-3.53 / -1.54%
  • Shares traded2.40m
  • 1 Year change+75.22%
  • Beta0.6175
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

  • Revenue in USD (TTM)244.67bn
  • Net income in USD1.66bn
  • Incorporated1979
  • Employees57.70k
More ▼

Institutional shareholders

35.79%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202529.07m12.23%
BlackRock Fund Advisorsas of 31 Dec 202514.69m6.18%
SSgA Funds Management, Inc.as of 31 Dec 202512.51m5.27%
Geode Capital Management LLCas of 31 Dec 20256.53m2.75%
Wellington Management Co. LLPas of 31 Dec 20254.86m2.05%
WCM Investment Management LLCas of 31 Dec 20254.03m1.70%
Norges Bank Investment Managementas of 31 Dec 20253.85m1.62%
BlackRock Investment Management (UK) Ltd.as of 31 Dec 20253.23m1.36%
BlackRock Advisors LLCas of 31 Dec 20253.17m1.34%
Fidelity Management & Research Co. LLCas of 31 Dec 20253.08m1.30%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.